Benign Prostatic Hyperplasia: Clinical Trials

4 trials for Benign Prostatic Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Benign Prostatic Hyperplasia: new trials by email Literature Review of Benign Prostatic Hyperplasia trials Research Report on Benign Prostatic Hyperplasia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction
Targeted Microwave Ablation - Benign Prostatic Hyperplasia
Phase 2TerminatedAssistance Publique - Hôpitaux de Paris82024-04-242026-10-01
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo - Benign Prostatic Hyperplasia
Phase 2TerminatedOPKO Health, Inc.1142018-02-212021-09-16
A Study in Men With Benign Prostatic Hyperplasia
LY500307, Placebo - Benign Prostatic Hyperplasia
Phase 2TerminatedEli Lilly and Company4142010-04-012019-04-08
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Lonidamine - Benign Prostatic Hyperplasia
Phase 2TerminatedThreshold Pharmaceuticals2402005-06-012009-04-29

Narrower conditions

Prostatic Hyperplasia (4)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Male Urogenital Diseases (4)  ·  Prostatic Diseases (4)  ·  Urogenital Diseases (4)

Interventions

erteberel (1)  ·  lonidamine (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Eli Lilly and Company (1)  ·  OPKO Health, Inc. (1)  ·  Threshold Pharmaceuticals (1)

Countries

United States (3)  ·  France (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Russia (1)

Top investigators

Militza Vera De Alba, MD (1)